Palisade bio appoints gi clinical expert and biotech entrepreneur mitchell jones, m.d., ph.d. as chief medical officer

Announces awarding of inducement grant to new chief medical officer carlsbad, ca, sept. 11, 2023 (globe newswire) -- palisade bio, inc. (nasdaq: pali) (“palisade” or the “company”), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (gi) complications, today announced the appointment of mitchell jones, m.d.
PALI Ratings Summary
PALI Quant Ranking